Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Yap

Showing results (51-60 of 260) with videos related to

Pageof 26
Sort By:
Expert Review of Anticancer Therapy|October 27, 2012
Cabazitaxel in metastatic castration-resistant prostate cancerTimothy A Yap, Carmel J Pezaro, Johann S de Bono
Current Opinion in Oncology|July 5, 2022
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinationsNatalie Y L Ngoi, Shannon N Westin, Timothy A Yap
European Journal of Cancer (Oxford, England : 1990)|November 21, 2009
Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspectiveShahneen K Sandhu, Timothy A Yap, Johann S de Bono
Current Drug Targets|July 23, 2011
The emerging role of poly(ADP-Ribose) polymerase inhibitors in cancer treatmentShahneen K Sandhu, Timothy A Yap, Johann S de Bono
Nature Reviews. Clinical Oncology|August 10, 2011
The changing therapeutic landscape of castration-resistant prostate cancerTimothy A Yap, Andrea Zivi, Aurelius Omlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2016
Biopsy-Derived Biomarkers in Phase I Trials: Building Confidence in Drug DevelopmentTimothy A Yap, Udai Banerji, Johann S de Bono, et al.
Cancer Discovery|December 23, 2016
Targeting DNA Repair in Cancer: Beyond PARP InhibitorsJessica S Brown, Brent O'Carrigan, Stephen P Jackson, et al.
British Journal of Cancer|July 10, 2023
PARP inhibitors: enhancing efficacy through rational combinationsDeepak Bhamidipati, Jaime I Haro-Silerio, Timothy A Yap, et al.
Frontiers in Medicine|April 27, 2017
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung CancerRaghav Sundar, Maxime Chénard-Poirier, Dearbhaile Catherine Collins, et al.
British Journal of Cancer|January 7, 2015
Combining targeted therapeutics in the era of precision medicineD Papadatos-Pastos, M J De Miguel Luken, Timothy A Yap
Pageof 26

Showing results (51-60 of 260) with videos related to

Sort By:
Pageof 26
Expert Review of Anticancer Therapy|October 27, 2012
Cabazitaxel in metastatic castration-resistant prostate cancerTimothy A Yap, Carmel J Pezaro, Johann S de Bono
Current Opinion in Oncology|July 5, 2022
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinationsNatalie Y L Ngoi, Shannon N Westin, Timothy A Yap
European Journal of Cancer (Oxford, England : 1990)|November 21, 2009
Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspectiveShahneen K Sandhu, Timothy A Yap, Johann S de Bono
Current Drug Targets|July 23, 2011
The emerging role of poly(ADP-Ribose) polymerase inhibitors in cancer treatmentShahneen K Sandhu, Timothy A Yap, Johann S de Bono
Nature Reviews. Clinical Oncology|August 10, 2011
The changing therapeutic landscape of castration-resistant prostate cancerTimothy A Yap, Andrea Zivi, Aurelius Omlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2016
Biopsy-Derived Biomarkers in Phase I Trials: Building Confidence in Drug DevelopmentTimothy A Yap, Udai Banerji, Johann S de Bono, et al.
Cancer Discovery|December 23, 2016
Targeting DNA Repair in Cancer: Beyond PARP InhibitorsJessica S Brown, Brent O'Carrigan, Stephen P Jackson, et al.
British Journal of Cancer|July 10, 2023
PARP inhibitors: enhancing efficacy through rational combinationsDeepak Bhamidipati, Jaime I Haro-Silerio, Timothy A Yap, et al.
Frontiers in Medicine|April 27, 2017
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung CancerRaghav Sundar, Maxime Chénard-Poirier, Dearbhaile Catherine Collins, et al.
British Journal of Cancer|January 7, 2015
Combining targeted therapeutics in the era of precision medicineD Papadatos-Pastos, M J De Miguel Luken, Timothy A Yap
Pageof 26